Increased short-term blood pressure variability is associated with early left ventricular systolic dysfunction in newly diagnosed untreated hypertensive patients

Journal of Hypertension

Volumn 31, Issue 8, 2013, Pages 1653-1661

  Tatasciore, Alfonso ^a,b,e   Zimarino, Marco ^a,b,e   Tommasi, Roberto ^a,b,e   Renda, Giulia ^a,b,e   Schillaci, Giuseppe ^c,d   Parati, Gianfranco ^e   De Caterina, Raffaele ^a,b,e  

^a UNIVERSITY OF CHIETI   (Italy)

^b Department of Clinical and Experimental Medicine ^*  (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d University Hospital of Terni   (Italy)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

blood pressure variability; hypertension; left ventricular systolic function; midwall fractional shortening

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; HYPERTENSION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; WAKEFULNESS; WALL STRESS;

EID: 84880572978     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328361e4a6     Document Type: Article

References (46)

1. Cuspidi C, Lonati L, Sampieri L, Michev I, Macca G, Rocanova JI, et al. Prevalence of target organ damage in treated hypertensive patients: different impact of clinic and ambulatory blood pressure control. J Hypertens 2000; 18:803-809.
2. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-h blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987; 5:93-98.
3. Parati G. Blood pressure variability: its measurement and significance in hypertension. J Hypertens Suppl 2005; 23:S19-S25.
4. Tatasciore A, Renda G, Zimarino M, Soccio M, Bilo G, Parati G, et al. Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension 2007; 50:325-332.
5. Verdecchia P, Angeli F, Gattobigio R, Sardone M, Porcellati C. Asymptomatic left ventricular systolic dysfunction in essential hypertension: prevalence, determinants, and prognostic value. Hypertension 2005; 45:412-418.
6. Parati G, Valentini M. Prognostic relevance of blood pressure variability. Hypertension 2006; 47:137-138.
7. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensivedrug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 2010; 375:906-915.
8. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. The task force for the management of arterial hypertension of the European Society of H, The task force for the management of arterial hypertension of the European Society of C. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28:1462-1536.
9. Sweitzer NK, Lopatin M, Yancy CW, Mills RM, Stevenson LW. Comparison of clinical features and outcomes of patients hospitalized with heart failure and normal ejection fraction (> orU55%) versus those with mildly reduced (40% to 55%) and moderately to severely reduced (<40%) fractions. Am J Cardiol 2008; 101:1151-1156.
10. Bilo G, Giglio A, Styczkiewicz K, Caldara G, Kawecka-Jaszcz K, Mancia G, Parati G. How to improve the assessment of 24-h blood pressure variability. Blood Press Monit 2005; 10:321-323.
11. Bilo G, Giglio A, Styczkiewicz K, Caldara G, Maronati A, Kawecka- Jaszcz K, et al. A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J Hypertens 2007; 25:2058-2066.
12. Verdecchia P, Schillaci G, Porcellati C. Dippers versus nondippers. J Hypertens Suppl 1991; 9:S42-S44.
13. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21:821-848.
14. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
15. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
16. Ballo P, Mondillo S, Guerrini F, Barbati R, Picchi A, Focardi M. Midwall mechanics in physiologic and hypertensive concentric hypertrophy. J Am Soc Echocardiogr 2004; 17:418-427.
17. Ballo P, Quatrini I, Giacomin E, Motto A, Mondillo S. Circumferential versus longitudinal systolic function in patients with hypertension: a nonlinear relation. J Am Soc Echocardiogr 2007; 20:298-306.
18. Schillaci G, Verdecchia P, Reboldi G, Pede S, Porcellati C. Subclinical left ventricular dysfunction in systemic hypertension and the role of 24-h blood pressure. Am J Cardiol 2000; 86:509-513.
19. Wachtell K, Palmieri V, Olsen MH, Gerdts E, Papademetriou V, Nieminen MS, et al. Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) study. Circulation 2002; 106:227-232.
20. Shimizu G, Hirota Y, Kita Y, Kawamura K, Saito T, Gaasch WH. Left ventricular midwall mechanics in systemic arterial hypertension. Myocardial function is depressed in pressure-overload hypertrophy. Circulation 2001; 83:1676-1684.
21. de Simone G, Devereux RB, Koren MJ, Mensah GA, Casale PN, Laragh JH. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation 1996; 93:259-265.
22. Shimizu G, Zile MR, Blaustein AS, Gaasch WH. Left ventricular chamber filling and midwall fiber lengthening in patients with left ventricular hypertrophy: overestimation of fiber velocities by conventional midwall measurements. Circulation 1985; 71:266-272.
23. Gaasch WH, Zile MR, Hoshino PK, Apstein CS, Blaustein AS. Stressshortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy. Circulation 1989; 79:872-883.
24. Borow KM, Green LH, Grossman W, Braunwald E. Left ventricular endsystolic stress-shortening and stress-length relations in human. Normal values and sensitivity to inotropic state. Am J Cardiol 1982; 50:1301-1308.
25. Colan SD, Borow KM, Neumann A. Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility. J Am Coll Cardiol 1984; 4:715-724.
26. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
27. Tatasciore A, Zimarino M, Renda G, Zurro M, Soccio M, Prontera C, et al. Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension. Hypertens Res 2008; 31:2137-2146.
28. Sander D, Kukla C, Klingelhofer J, Winbeck K, Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation 2000; 102:1536-1541.
29. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999; 282:539-546.
30. Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 2000; 36:901-906.
31. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ, et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension 2007; 49:1265-1270.
32. Schillaci G, Vaudo G, Pasqualini L, Reboldi G, Porcellati C, Verdecchia P. Left ventricular mass and systolic dysfunction in essential hypertension. J Hum Hypertens 2002; 16:117-122.
33. Zabalgoitia M, Berning J, Koren MJ, Stoylen A, Nieminen MS, Dahlof B, Devereux RB. Impact of coronary artery disease on left ventricular systolic function and geometry in hypertensive patients with left ventricular hypertrophy (the LIFE study). Am J Cardiol 2001; 88:646-650.
34. Koulouris SN, Kostopoulos KG, Triantafyllou KA, Karabinos I, Bouki TP, Karvounis HI, et al. Impaired systolic dysfunction of left ventricular longitudinal fibers: a sign of early hypertensive cardiomyopathy. Clin Cardiol 2005; 28:282-286.
35. Kramer CM, Reichek N, Ferrari VA, Theobald T, Dawson J, Axel L. Regional heterogeneity of function in hypertrophic cardiomyopathy. Circulation 1994; 90:186-194.
36. Aurigemma GP, Silver KH, McLaughlin M, Mauser J, Gaasch WH. Impact of chamber geometry and gender on left ventricular systolic function in patients > 60 years of age with aortic stenosis. Am J Cardiol 1994; 74:794-798.
37. Kozakova M, Ferrannini E, Palombo C. Relation between left ventricular midwall function and coronary vasodilator capacity in arterial hypertension. Hypertension 2003; 42:528-533.
38. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, et al. Effects of beta blockers and calcium-channel blockers on withinindividual variability in blood pressure and risk of stroke. Lancet Neurol 2010; 9:469-480.
39. Wachtell K, Bella JN, Liebson PR, Gerdts E, Dahlof B, Aalto T, et al. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study. Hypertension 2000; 35:6-12.
40. Zimarino M, Cappelletti L, Venarucci V, Gallina S, Scarpignato M, Acciai N, et al. Age-dependence of risk factors for carotid stenosis: an observational study among candidates for coronary arteriography. Atherosclerosis 2001; 159:165-173.
41. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114:345-352.
42. Zimarino M, Prati F, Stabile E, Pizzicannella J, Fouad T, Filippini A, et al. Optical coherence tomography accurately identifies intermediate atherosclerotic lesions: an in vivo evaluation in the rabbit carotid artery. Atherosclerosis 2007; 193:94-101.
43. Schillaci G, Parati G. Determinants of blood pressure variability in youth: at the roots of hypertension. J Hypertens 2010; 28:660-664.
44. Price DJA, Wallbridge DR, Stewart MJ. Tissue Doppler imaging: current and potential clinical applications. Heart 2000; 84:ii11-ii18.
45. Van de Veire NR, De Sutter J, Bax JJ, Roelandt Jr. Technological advances in tissue Doppler imaging echocardiography. Heart 2008; 94:1065-1074.
46. Palmieri V, Arezzi E, Sabatella M, Celentano A. Interstudy reproducibility of parameters of left ventricular diastolic function: a Doppler echocardiography study. J Am Soc Echocardiogr 2003; 16:1128-1135.